For media inquiries, please contact press@allazohealth.com
AI-Enabled Dynamic Modular Content is a first-of-its-kind solution that empowers pharmaceutical companies to customize an individual patient’s digital engagement and improve health outcomes NEW YORK, NY – September 24, 2024 – AllazoHealth, the pioneer in driving…
Read More
New York, NY – AllazoHealth was selected as a winner in the Spring 2024 Digital Health Awards program. This competition recognizes the best digital health companies and resources in the United States. The AllazoHealth AI…
New York, NY – AllazoHealth, the pioneer in delivering AI-driven personalized healthcare experiences, has been named the winner of a Gold Stevie® Award in the Artificial Intelligence/ Machine Learning Solution – Healthcare category in The…
New York, NY — AllazoHealth, the pioneer in delivering AI-driven healthcare experiences, has been selected by PM360 as part of its prestigious annual Innovations Issue, which highlights the most forward-thinking advancements in the life sciences, healthcare, and marketing in 13 categories.
AllazoHealth, a company that uses artificial intelligence to help pharmaceuticals, payers, and pharmacies improve medication adherence and quality outcomes, announced today that pharmaceutical industry veteran Mark Degatano will be joining the company’s Advisory Board.
Read moreNew York, NY – AllazoHealth announced today that William Grambley will take on the position of Chief Executive Officer after serving more than two years as Chief Operating Officer at the fast-growing healthcare AI company.…
Read moreIn the Fall 2019 edition of BioSupply Trends Quarterly, AllazoHealth CEO William Grambley shares how artificial intelligence (AI) will change the healthcare landscape. “There are so many places where AI is impacting people’s lives that…
Read moreNEW YORK, NY and FORT MILL, SC (March 4, 2019) – Lash Group, a patient support services company and a part of AmerisourceBergen, and AllazoHealth, an artificial intelligence (AI) and predictive analytics company focused on ensuring optimal patient outcomes, today announced
Read moreAllazoHealth has co-published a randomized controlled study with Blue Cross Blue Shield of North Carolina.
Read moreNew York, NY – AllazoHealth, the AI and predictive analytics company focused on predicting and changing patient behaviors through precision engagement, announced today that Steve Cohan will be joining the company’s Advisory Board. Prior to joining…
Read moreNew York, NY – AllazoHealth, the healthcare technology company using Artificial Intelligence to predict and change patient behavior through precision engagement, announced today that Bill Grambley has joined the company as Chief Operating Officer. Prior…
Read moreIn the September 2018 issue of MM&M, Davin Cho, VP of commercial strategy at AllazoHealth, outlines the future of medication adherence in the feature, “Adherence Intelligence is the New AI.” While medication non-adherence isn’t a…
Read moreNew York, NY – AllazoHealth, the industry leader in optimizing medication adherence programs through artificial intelligence (AI), today announced that its AllazoEngine™ platform was named the winner of the Data Analytics & Business Intelligence category…
Read moreDownload our infographic to learn how manufacturers can drive patient behaviors for better therapy initiation, adherence, and health outcomes using AI-powered personalization at the individual level.
Download InfographicExplore our comprehensive media kit that’s been curated to provide the AllazoHealth experience. Delve into a diverse array of content such as logos, headshots, content, and the latest news that showcases the depth and breadth of our offerings.
Download Media Kit